315 related articles for article (PubMed ID: 4907453)
1. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.
Schwab RS; England AC
Trans Am Neurol Assoc; 1969; 94():85-90. PubMed ID: 4907453
[No Abstract] [Full Text] [Related]
2. [Treatment of Parkinson's disease with amantadine].
Sigwald J; Raymondeaud C; Grégoire J
Therapeutique; 1972 Nov; 48(9):555-60. PubMed ID: 4568230
[No Abstract] [Full Text] [Related]
3. L-dopa and amantadine hydrochloride in Parkinson's disease.
Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R
Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417
[No Abstract] [Full Text] [Related]
4. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
Sigwald J; Raymondeaud C; Piot C
Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718
[No Abstract] [Full Text] [Related]
5. [Clinical trial of the therapeutic effect of Amantadine-HCL in Parkinson's Disease].
Hacohen H; Gurtner B
Schweiz Med Wochenschr; 1972 Apr; 102(16):583-6. PubMed ID: 5019377
[No Abstract] [Full Text] [Related]
6. Treatment of Parkinson's disease with amantadine and L-Dopa.
Rinne UK; Sonninen V; Siirtola T
Eur Neurol; 1972; 7(4):228-40. PubMed ID: 4556618
[No Abstract] [Full Text] [Related]
7. [Preliminary observations on the use of intravenous amantadine and of the association of oral amantadine with anticholinergic drugs and with levo-dopa in the treatment of Parkinson's disease].
Fasano VA; Urciuoli R; Broggi G
Minerva Med; 1970 Jul; 61(53):2895-903. PubMed ID: 5428170
[No Abstract] [Full Text] [Related]
8. The treatment with L-dopa and amantadine in Parkinson's disease.
Pendefunda G; Pollingher B; Stefanache F; Gavril A; Oprisan C; Merling M; Nemteanu E; Ciunru M; Koropitzer I
Ther Hung; 1975; 23(1):12-6. PubMed ID: 1105871
[No Abstract] [Full Text] [Related]
9. [Effects of additional medication of Amantadine sulfate in L-dopa-pretreated patients with Parkinson's syndrome (author's transl)].
Schneider E; Fischer PA; Jacobi P
Med Klin; 1974 Mar; 69(13):541-5. PubMed ID: 4831456
[No Abstract] [Full Text] [Related]
10. Treatment of Parkinson's disease with amantadine (Symmetrel).
van Manen J
Psychiatr Neurol Neurochir; 1972; 75(1):49-59. PubMed ID: 5024896
[No Abstract] [Full Text] [Related]
11. Controlled trial of amantadine hydrochloride in Parkinson's disease.
Jorgensen PB; Bergin JD; Haas L; Cuningham JA; Morah DD; Pollock M; Robinson RG; Spears GF
N Z Med J; 1971 May; 73(468):263-7. PubMed ID: 4932146
[No Abstract] [Full Text] [Related]
12. Long-term therapy of Parkinson's disease with amantadine, alone and combined with levodopa.
Zeldowicz LR; Hubermann J
Can Med Assoc J; 1973 Oct; 109(7):588-93. PubMed ID: 4582563
[TBL] [Abstract][Full Text] [Related]
13. [Amantadine hydrochloride in the treatment of Parkinson's syndrome].
De la Herrán J; Figuerido JA
Rev Esp Otoneurooftalmol Neurocir; 1971; 29(167):45-9. PubMed ID: 5091472
[No Abstract] [Full Text] [Related]
14. A controlled study of the clinical effects of amantadine hydrochloride (Symmetrel).
Merrick EM; Schmitt PP
Curr Ther Res Clin Exp; 1973 Aug; 15(8):552-8. PubMed ID: 4200529
[No Abstract] [Full Text] [Related]
15. Double blind study using amantadine hydrochloride in the therapy of Parkinson's disease.
Silver DE; Sahs AL
Trans Am Neurol Assoc; 1971; 96():307-8. PubMed ID: 4945919
[No Abstract] [Full Text] [Related]
16. [Amantadine treatment in Parkinson's disease].
Boman K; Kivalo E; Porras J
Nord Med; 1970 Nov; 84(48):1518-20. PubMed ID: 4922228
[No Abstract] [Full Text] [Related]
17. Combined treatment of parkinsonism with L-dopa and amantadine.
Godwin-Austen RB; Frears CC; Bergmann S; Parkes JD; Knill-Jones RP
Lancet; 1970 Aug; 2(7669):383-5. PubMed ID: 4194690
[No Abstract] [Full Text] [Related]
18. Amantadine hydrochloride in treatment of Parkinsonism.
Nagaswami S; Nagaswami R
Dis Nerv Syst; 1973; 34(5):253-8. PubMed ID: 4782280
[No Abstract] [Full Text] [Related]
19. Comparison of amantadine, placebo, and levodopa in Parkinson's disease.
Bauer RB; McHenry JT
Neurology; 1974 Aug; 24(8):715-20. PubMed ID: 4858417
[No Abstract] [Full Text] [Related]
20. L-dopa and amantadine in the therapy of parkinsonism.
Weeth JB; Shealy CN; Mercier DA
Wis Med J; 1969 Nov; 68(11):325-8. PubMed ID: 4901055
[No Abstract] [Full Text] [Related]
[Next] [New Search]
